Multinational pharma increasing operations and investment in India

Holding sway in the Indian market, multinational pharmaceutical companies are looking to increase their market share in the $33 billion domestic industry. Taking note of the new opportunities, many global majors have begun to make meaningful investments in the country, reports The Pharma Letter’s India correspondent.

Experts point out India’s population is growing rapidly, as is its economy, creating a large middle class with the resources to afford Western medicines.

India’s epidemiological profile is also changing, so demand is likely to increase for drugs for cardiovascular problems, disorders of the central nervous system and other chronic diseases. Together these factors mean that India represents a promising potential market for global pharmaceutical manufacturers.